Comparative effectiveness of heterologous third dose vaccine schedules against severe covid-19 during omicron predominance in Nordic countries: population based cohort analyses | The BMJ
Is the advantage conferred by the heterologous regimen conserved after a booster dose of mRNA-based COVID-19 vaccine?
Homologous and Heterologous Covid-19 Booster Vaccinations | NEJM
Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study - The Lancet
DCGI approves Biological E's COVID-19 vaccine Corbevax as heterologous booster dose | Zee Business
Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial - The Lancet
EU Medicines Agency on X: "‼️ EMA & @ECDC_EU share their recommendations on the possibility of using 2 different #COVID19vaccines, either for the 1st and 2nd doses of a primary course, or
Heterologous COVID-19 booster doses show 68 percent effectiveness
Corbevax gets DCGI nod as heterologous Covid booster dose for adults | Mint
Safety of heterologous primary and booster schedules with ChAdOx1-S and BNT162b2 or mRNA-1273 vaccines: nationwide cohort study | The BMJ
Vaccines | Free Full-Text | Heterologous Booster Dose with CORBEVAX following Primary Vaccination with COVISHIELD Enhances Protection against SARS-CoV-2
Explained | What is a heterologous booster vaccine, and what are its advantages? - The Hindu
Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccination | Nature Medicine
Protection of homologous and heterologous boosters after primary schemes of rAd26-rAd5, ChAdOx1 nCoV-19 and BBIBP-CorV during the omicron outbreak in adults of 50 years and older in Argentina: a test-negative case–control study -
Neutralizing antibodies against the SARS-CoV-2 Delta and Omicron variants following heterologous CoronaVac plus BNT162b2 booster vaccination | Nature Medicine
Vaccines | Free Full-Text | Heterologous Booster Dose with CORBEVAX following Primary Vaccination with COVISHIELD Enhances Protection against SARS-CoV-2
A 'mix and match' approach to SARS-CoV-2 vaccination | Nature Medicine
Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study - The Lancet
Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study - The Lancet
Comparative effectiveness and safety of homologous two-dose ChAdOx1 versus heterologous vaccination with ChAdOx1 and BNT162b2 | Nature Communications
Effectiveness of CoronaVac, AZD1222, and BNT162b2 vaccine boosters
Covid-19 vaccine mixing: could heterologous boosters improve immunity?
Govt panel likely to decide on Covovax as a heterologous booster dose for adults on Wednesday, ET HealthWorld
NTAGI holds meeting on Covovax inclusion as heterologous booster on CoWin portal, ET HealthWorld
